Apollomics, Inc. (APLM) vs Dogwood Therapeutics, Inc. (DWTX)
A side-by-side comparison of Apollomics, Inc. and Dogwood Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
APLM
Apollomics, Inc.
$22.47HealthcareDelayed quote: Oct 6, 2026, 3:34 PM EDT
DWTX
Dogwood Therapeutics, Inc.
$1.56HealthcareDelayed quote: Oct 6, 2026, 3:34 PM EDT
Total return — APLM vs DWTX
growth of $100 · dividends reinvested · last 5yAPLM -97.6% (-52.8%/yr)DWTX -98.8% (-58.5%/yr)APLM compounded faster over this window
APLM DWTX
APLM vs DWTX: by the numbers
- •DWTX is the larger company ($52M vs $49M market cap).
- •Both run net losses; DWTX's is the smaller (0.00% vs -128.69% net margin).
Metrics side by side
Valuation
| Metric | APLM | DWTX |
|---|---|---|
| P/B ratio | N/A | 0.77 |
Profitability
| Metric | APLM | DWTX |
|---|---|---|
| Gross margin | 97.00% | 0.00% |
| Operating margin | -111.45% | 0.00% |
| Net margin | -128.69% | 0.00% |
| ROE | N/A | -52.72% |
| ROIC | -2441.49% | -38.04% |
Growth (annualized)
| Metric | APLM | DWTX |
|---|---|---|
| Revenue CAGR (5Y) | 35.84% | N/A |
| Total return CAGR (5Y) | N/A | -58.44% |
Go deeper
Dig into the metrics
Apollomics ROEDogwood Therapeutics ROEApollomics operating marginDogwood Therapeutics operating marginApollomics revenue growthDogwood Therapeutics revenue growthApollomics free cash flowDogwood Therapeutics free cash flow
Apollomics & Dogwood Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.